Inventor
BARLAAM BERNARD CHRISTOPHE
GB31 patents
⚠️ This page may combine multiple inventors who share the name “BARLAAM BERNARD CHRISTOPHE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTRAZENECA AB
29 patentsUS6518301B1Feb 11, 2003
Estrogen receptor-β ligands
ASTRAZENECA AB60 citations92
US7718653B2May 18, 2010
Pyrimidine derivatives for inhibiting Eph receptors
ASTRAZENECA AB26 citations89
US8673906B2Mar 18, 2014
Chromenone derivatives
ASTRAZENECA AB17 citations88
US9029374B2May 12, 2015
Chromenone derivatives
ASTRAZENECA AB5 citations82
US9856255B2Jan 2, 2018
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
ASTRAZENECA AB3 citations72
US10457679B2Oct 29, 2019
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
ASTRAZENECA AB3 citations71
US10131663B2Nov 20, 2018
Chemical compounds
ASTRAZENECA AB2 citations71
US11613539B2Mar 28, 2023
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
ASTRAZENECA AB0 citations61
US11046689B2Jun 29, 2021
Selective estrogen receptor down-regulators
ASTRAZENECA AB0 citations61
US10882858B2Jan 5, 2021
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
ASTRAZENECA AB0 citations61
US7122551B2Oct 17, 2006
Metalloproteinase inhibitor compounds
ASTRAZENECA AB2 citations61
US12077530B2Sep 3, 2024
Chemical compounds
ASTRAZENECA AB0 citations60
US10961241B2Mar 30, 2021
Chemical compounds
ASTRAZENECA AB0 citations60
US8017611B2Sep 13, 2011
Pyridine and pyrazine derivatives -083
ASTRAZENECA AB2 citations56
US7342020B2Mar 11, 2008
Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP)
ASTRAZENECA AB0 citations52
US10189834B2Jan 29, 2019
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
ASTRAZENECA AB0 citations51
US9822111B2Nov 21, 2017
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
ASTRAZENECA AB0 citations51
US9428503B2Aug 30, 2016
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating Cancer
ASTRAZENECA AB0 citations51
US10590130B2Mar 17, 2020
Chemical compounds
ASTRAZENECA AB0 citations50
US10590132B2Mar 17, 2020
Selective estrogen receptor down-regulators
ASTRAZENECA AB0 citations50
US10221173B2Mar 5, 2019
Chemical compounds
ASTRAZENECA AB0 citations50
US9718800B2Aug 1, 2017
Chromenone derivatives
ASTRAZENECA AB0 citations50
US9657008B2May 23, 2017
Chemical compounds
ASTRAZENECA AB1 citations50
US9156831B2Oct 13, 2015
Chemical compounds
ASTRAZENECA AB0 citations50
US7838530B2Nov 23, 2010
Quinazoline derivatives as antiproliferative agents
ASTRAZENECA AB1 citations50
US10125135B2Nov 13, 2018
Chemical compounds
ASTRAZENECA AB0 citations48
US10149839B2Dec 11, 2018
Chemical compounds
ASTRAZENECA AB0 citations47
US7947676B2May 24, 2011
Pyrazolo[3,4-d]pyrimidine compounds as antitumor agents
ASTRAZENECA AB0 citations39
US7820683B2Oct 26, 2010
4-(1H-indazol-5-yl-amino)-quinazoline compounds as erbB receptor tyrosine kinase inhibitors for the treatment of cancer
ASTRAZENECA AB0 citations39